Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yan-ping Zhang

Showing results (271-280 of 278) with videos related to

Pageof 28
Sort By:
You have reached the last page of results.This site can display upto 278 results.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|November 19, 2011
[Immunogenicity and safety of DTaP-IPV//PRP-T combined vaccine in infants in China]Yan-ping Li, Feng-xiang Li, Qi-ming Hou, et al.
Vaccine|October 18, 2011
Antibody persistence at 18-20 months of age and safety and immunogenicity of a booster dose of a combined DTaP-IPV//PRP∼T vaccine compared to separate vaccines (DTaP, PRP∼T and IPV) following primary vaccination of healthy infants in the People's Republic of ChinaRong Cheng Li, Feng Xiang Li, Yan Ping Li, et al.
Vaccine|January 12, 2011
Immunogenicity and safety of a pentavalent acellular pertussis combined vaccine including diphtheria, tetanus, inactivated poliovirus and conjugated Haemophilus Influenzae type b polysaccharide for primary vaccination at 2, 3, 4 or 3, 4, 5 months of age in infants in ChinaRong Cheng Li, Feng Xiang Li, Yan Ping Li, et al.
The Lancet. Respiratory Medicine|May 20, 2023
Safety and immunogenicity of heterologous boosting with orally aerosolised or intramuscular Ad5-nCoV vaccine and homologous boosting with inactivated vaccines (BBIBP-CorV or CoronaVac) in children and adolescents: a randomised, open-label, parallel-controlled, non-inferiority, single-centre studyTao Huang, Sheng Zhang, De-Fang Dai, et al.
The Lancet Regional Health. Western Pacific|December 8, 2025
Epidemiological analysis of infectious diseases in older people in China from 2014 to 2022: a population-based studySheng-Hong Lin, Chen-Long Lv, Meng-Jie Geng, et al.
World Journal of Pediatrics : WJP|August 4, 2025
Single-dose GC101 gene therapy for spinal muscular atrophy types II and III: an open-label single-arm studyXiu-Wei Ma, Xin-Yang Jiang, Zhong-Qiu Li, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|November 10, 2021
The Melastoma dodecandrum genome and the evolution of MyrtalesYang Hao, Yu-Zhen Zhou, Bin Chen, et al.
The New England Journal of Medicine|March 18, 2011
Fever with thrombocytopenia associated with a novel bunyavirus in ChinaXue-Jie Yu, Mi-Fang Liang, Shou-Yin Zhang, et al.
Pageof 28

Showing results (271-280 of 278) with videos related to

Sort By:
Pageof 28
You have reached the last page of results.This site can display upto 278 results.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|November 19, 2011
[Immunogenicity and safety of DTaP-IPV//PRP-T combined vaccine in infants in China]Yan-ping Li, Feng-xiang Li, Qi-ming Hou, et al.
Vaccine|October 18, 2011
Antibody persistence at 18-20 months of age and safety and immunogenicity of a booster dose of a combined DTaP-IPV//PRP∼T vaccine compared to separate vaccines (DTaP, PRP∼T and IPV) following primary vaccination of healthy infants in the People's Republic of ChinaRong Cheng Li, Feng Xiang Li, Yan Ping Li, et al.
Vaccine|January 12, 2011
Immunogenicity and safety of a pentavalent acellular pertussis combined vaccine including diphtheria, tetanus, inactivated poliovirus and conjugated Haemophilus Influenzae type b polysaccharide for primary vaccination at 2, 3, 4 or 3, 4, 5 months of age in infants in ChinaRong Cheng Li, Feng Xiang Li, Yan Ping Li, et al.
The Lancet. Respiratory Medicine|May 20, 2023
Safety and immunogenicity of heterologous boosting with orally aerosolised or intramuscular Ad5-nCoV vaccine and homologous boosting with inactivated vaccines (BBIBP-CorV or CoronaVac) in children and adolescents: a randomised, open-label, parallel-controlled, non-inferiority, single-centre studyTao Huang, Sheng Zhang, De-Fang Dai, et al.
The Lancet Regional Health. Western Pacific|December 8, 2025
Epidemiological analysis of infectious diseases in older people in China from 2014 to 2022: a population-based studySheng-Hong Lin, Chen-Long Lv, Meng-Jie Geng, et al.
World Journal of Pediatrics : WJP|August 4, 2025
Single-dose GC101 gene therapy for spinal muscular atrophy types II and III: an open-label single-arm studyXiu-Wei Ma, Xin-Yang Jiang, Zhong-Qiu Li, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|November 10, 2021
The Melastoma dodecandrum genome and the evolution of MyrtalesYang Hao, Yu-Zhen Zhou, Bin Chen, et al.
The New England Journal of Medicine|March 18, 2011
Fever with thrombocytopenia associated with a novel bunyavirus in ChinaXue-Jie Yu, Mi-Fang Liang, Shou-Yin Zhang, et al.
Pageof 28